For: | Xue XJ, Li FR, Yu J. Mitochondrial pathway of the lysine demethylase 5C inhibitor CPI-455 in the Eca-109 esophageal squamous cell carcinoma cell line. World J Gastroenterol 2021; 27(16): 1805-1815 [PMID: 33967558 DOI: 10.3748/wjg.v27.i16.1805] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i16/1805.htm |
Number | Citing Articles |
1 |
Jun He, Zejing Qiu, Jingjing Fan, Xiaohong Xie, Qinsong Sheng, Xinbing Sui. Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01891-4
|
2 |
Tian Guan, Yingshuang Zhang, Shen Li, Wenbao Zhang, Yuxuan Song, Yuzhan Li, Yundong He, Yihua Chen. Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer. European Journal of Medicinal Chemistry 2024; 272: 116494 doi: 10.1016/j.ejmech.2024.116494
|
3 |
Dawid Dorna, Jarosław Paluszczak. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers. Cells 2022; 11(6): 1023 doi: 10.3390/cells11061023
|
4 |
Parul Ahuja, Ritu Yadav, Sandeep Goyal, Chetna Yadav, Shalu Ranga, Lokesh Kadian. Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches. Cell Biology and Toxicology 2023; 39(6): 2437 doi: 10.1007/s10565-023-09818-5
|